Idexx Laboratories (IDXX) Revenue (2009 - 2026)

Idexx Laboratories (IDXX) has reported Revenue for 18 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue rose 14.26% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $4.4 billion (up 13.08% YoY), while the FY2025 annual figure was $4.3 billion, up 10.42% from the prior year.
• Revenue came in at $1.1 billion for Q1 2026 at Idexx Laboratories, up from $1.1 billion in the prior quarter.
• The five-year high for Revenue was $1.1 billion in Q1 2026, with the low at $828.6 million in Q4 2022.
• Average Revenue over 5 years is $963.0 million, with a median of $954.3 million recorded in 2024.
• Across the five-year window, Revenue rose 3.43% in 2022 and climbed 14.28% in 2025, its largest moves.
• Year by year, Revenue stood at $828.6 million in 2022, then rose by 8.81% to $901.6 million in 2023, then grew by 5.84% to $954.3 million in 2024, then rose by 14.28% to $1.1 billion in 2025, then increased by 4.61% to $1.1 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.